Elizabeth Berry-Kravis

Overview

Best Publications

• Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates

  Sébastien Jacquemont;Randi J. Hagerman;Maureen Leehey;Jim Grigsby

  840
  Citations

• Fragile X syndrome

  Randi J. Hagerman;Elizabeth Berry-Kravis;Heather Cody Hazlett;Donald B. Bailey

  769
  Citations

• Penetrance of the Fragile X–Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population

  Sébastien Jacquemont;Randi J. Hagerman;Maureen A. Leehey;Deborah A. Hall

  716
  Citations

• Advances in the treatment of fragile x Syndrome

  Randi J Hagerman;Elizabeth Berry-Kravis;Walter E. Kaufmann;Michele Y. Ono

  667
  Citations

• Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

  Sébastien Jacquemont;Aurore Curie;Vincent des Portes;Maria Giulia Torrioli

  603
  Citations

• An Official ATS Clinical Policy Statement: Congenital Central Hypoventilation Syndrome: Genetic Basis, Diagnosis, and Management

  Debra E. Weese-Mayer;Elizabeth M. Berry-Kravis;Isabella Ceccherini;Thomas G. Keens

  516
  Citations

• Idiopathic congenital central hypoventilation syndrome: Analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b

  Debra E. Weese-Mayer;Elizabeth M. Berry-Kravis;Lili Zhou;Brion S. Maher

  510
  Citations

• SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research

  Pamela Feliciano;Amy M. Daniels;LeeAnne Green Snyder;Amy Beaumont

  462
  Citations

• A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

  Elizabeth M Berry-Kravis;David Hessl;Sarah Coffey;Crystal Hervey

  445
  Citations

• Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction

  James A. Brunberg;Sebastien Jacquemont;Randi J. Hagerman;Elizabeth M. Berry-Kravis

  434
  Citations

• Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

  Denis A. Evans;David A. Bennett;Robert S. Wilson;Julia L. Bienias

  404
  Citations

• FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States

  Flora Tassone;Ka Pou Iong;Tzu-Han Tong;Joyce Lo

  384
  Citations

• Congenital Central Hypoventilation Syndrome

  Elizabeth M. Berry-Kravis;Lili Zhou;Casey M. Rand;Debra E. Weese-Mayer

  384
  Citations

• Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial

  Elizabeth M. Berry-Kravis;David R Hessl;Barbara Rathmell;Peter Zarevics

  375
  Citations

• Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.

  Elizabeth Berry-Kravis;Liane Abrams;Sarah M. Coffey;Deborah A. Hall

  374
  Citations

• Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

  Daniel S Ory;Elizabeth A Ottinger;Nicole Yanjanin Farhat;Kelly A King

  338
  Citations

• Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome

  Elizabeth M. Berry-Kravis;Lothar Lindemann;Aia E. Jønch;Aia E. Jønch;George Apostol

  334
  Citations

• Apolipoprotein E ∈4 allele, AD pathology, and the clinical expression of Alzheimer's disease

  D.A. Bennett;R.S. Wilson;J.A. Schneider;D.A. Evans

  317
  Citations

• Epilepsy in fragile X syndrome.

  Elizabeth Berry-Kravis

  315
  Citations

• Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.

  Elizabeth Berry-Kravis;Allison Sumis;Crystal Hervey;Michael Nelson

  294
  Citations